Company intelligence / Profile preview

NattoPharma

Oslo, Norwaymenaq7.com ↗
Ownership
Private
Employees
~18
Development stage
Commercial
01

Overview

NattoPharma established the global market and scientific foundation for vitamin K2 as menaquinone‐7 (MK‐7), branded as MenaQ7®. Over twenty human clinical trials have demonstrated safety and efficacy in supporting bone and cardiovascular health. The company also developed a synthetic pharmaceutical-grade MK‐7 active pharmaceutical ingredient with documented purity, aiming at future drug development. Clinical research continues under the new parent company.

No approved drugs yet; commercialized globally as a supplement ingredient.

Therapeutic areas
Metabolic DisordersEndocrinologyCardiovascularOther
Modalities
Small moleculeSynthetic small moleculeNatural productNutraceutical ingredient
Industry
Food & Nutrition
02

Drug pipeline

1 asset

MenaQ7

Commercial
Indications
Bone health, Cardiovascular health
03

Partnerships

Notable partnership with Gnosis by Lesaffre post-acquisition; previously collaborated with various supplement manufacturers globally.

Beyond the preview

Go deeper on NattoPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NattoPharma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call